Skip to content
lifestyle.luxedb.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SAB Biotherapeutics, Inc.
SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
March 17, 2026
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
March 10, 2026
SAB BIO to Participate in Upcoming Investor Conferences
March 2, 2026
←
Previous Page
1
2